Practical solutions to resolve social barriers to hepatitis C treatment initiation among people who inject drugs: a qualitative study

Practical solutions to resolve social barriers to hepatitis C treatment initiation among people who inject drugs: a qualitative study

Abstract Background We aimed to identify motivators for people who inject drugs to pursue treatment for hepatitis C virus (HCV) infection and uncover opportunities that could make treatment more appealing. Methods Between November 2023 and January 2024, we conducted semi-structured interviews with 1...

Full description

Saved in:

Bibliographic Details
Main Authors:	Phyo Aung, Margaret Hellard, Paul Dietze, Bek Petrovic, Peter Higgs, Mark Stoové
Format:	Article
Language:	English
Published:	BMC 2024-12-01
Series:	Harm Reduction Journal
Subjects:	Practical solutions Hepatitis C treatment Behaviour change People who inject drugs Motivators
Online Access:	https://doi.org/10.1186/s12954-024-01136-1
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

How to eliminate hepatitis C between people who inject drugs in community services and prisons in Catalonia
by: Elena Yela, et al.
Published: (2025-07-01)

Experience and challenges delivering hepatitis C virus treatment for people who inject drugs in Kenya
by: Joyce Boke, et al.
Published: (2024-10-01)

Engagement in hepatitis C virus cascade of care and factors associated with testing among people who inject drugs in Iran
by: Mehrdad Khezri, et al.
Published: (2025-04-01)

Getting to full disclosure: HCV testing and status disclosure behaviors among PWID and their injecting partners
by: Maia Scarpetta, et al.
Published: (2025-05-01)

Predictors of future overdose among people who inject drugs in Baltimore, Maryland
by: Michael P. Ramirez, et al.
Published: (2024-12-01)

Methamphetamine use and associated factors among people who inject drugs in Iran 2020
by: Yasaman Mansoori, et al.
Published: (2025-04-01)

HIV and hepatitis C Virus in internally displaced people with and without injection drug use experience in the region of Shida Kartli, Georgia
by: Adrian Trovato, et al.
Published: (2024-10-01)

How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023
by: Mojca Maticic, et al.
Published: (2024-11-01)

A single-site randomized controlled trial of partner navigation to HCV treatment for people who inject drugs: a study protocol for the You’re Empowered for Treatment Initiation (YETI) partner trial
by: Meghan D. Morris, et al.
Published: (2025-01-01)

Current drug use patterns and HIV and HCV prevalence among people who inject drugs in suburban areas of Malaysia
by: Joselyn Pang, et al.
Published: (2025-05-01)

Findings from a Project Which Established Hepatitis C Point-of-Care Testing and Linkage to Care at a Homelessness Service in Adelaide, Australia, 2021–2022
by: Erin M. McCartney, et al.
Published: (2024-12-01)

Prevalence and willingness to access HIV services among people who inject drugs in the northern states of Nigeria
by: Ochonye Bartholomew Boniface, et al.
Published: (2025-01-01)

Recent HIV testing and self-reported HIV prevalence among men who inject drugs in Afghanistan: a nationwide survey in 2019–2020
by: Ajmal Sabawoon, et al.
Published: (2025-03-01)

Estimating the impact of direct acting antiviral therapy on the prevalence of hepatitis C virus infection using phylogenetics
by: Hossain M.S. Sazzad, et al.
Published: (2025-05-01)

A hand-washing community-based educational intervention to reduce abscess incidence among people who inject drugs: a cluster randomised controlled clinical trial protocol (the HAWA study protocol)
by: Liam Balhan, et al.
Published: (2024-10-01)

HCV and HIV co-infection among people who inject drugs in Vietnam
by: Vu Toan THINH, et al.
Published: (2020-12-01)

Exploring the value and acceptability of a patient navigator program for people who inject drugs and are hospitalized for bacterial infections: patients’, community organization and healthcare workers’ perspectives
by: Karine Bédard, et al.
Published: (2025-02-01)

Addiction consult service involvement in PrEP and PEP delivery for patients who inject drugs admitted to an urban essential hospital
by: Hallie Rozansky, et al.
Published: (2024-11-01)

Estimated number of people infected with hepatitis B and C virus in Germany in 2013: a baseline prevalence estimate using the workbook method
by: Katrin Kremer-Flach, et al.
Published: (2025-04-01)

Associations of HIV pre-exposure prophylaxis (PrEP) indication, HIV risk perception and unwillingness to use PrEP among people who inject drugs in Baltimore, MD
by: Tarfa Verinumbe, et al.
Published: (2024-12-01)

HCV Treatment Outcomes in PWID: Impact of Addiction History on SVR12
by: Ivana Milošević, et al.
Published: (2024-12-01)

Correlates of duration between initial drug use and first drug injection among people who inject drugs in Iran, 2020
by: Zahra Abdolahinia, et al.
Published: (2025-04-01)

Programmatic mapping and size estimation of people who inject drugs to plan targeted HIV prevention and harm reduction programs in iran, a nationwide study
by: Nima Ghalekhani, et al.
Published: (2025-07-01)

People Who Inject Drugs and have tuberculosis: Opioid Substitution Therapy improves treatment outcomes in Ukraine
by: Tetiana Fomenko, et al.
Published: (2021-09-01)

Experiences of women who inject Nyaope residing in the City of Tshwane Municipality, Gauteng
by: Moganki H. Lefoka, et al.
Published: (2025-05-01)

Understanding HIV vulnerability among women who inject drugs in Mozambique, 2023
by: Áuria Ribeiro Banze, et al.
Published: (2025-04-01)

Understanding drug-related harms as risk-amplifying loops among people who inject drugs in Sweden
by: Jessica Storbjörk, et al.
Published: (2025-07-01)

Drug use and sexual behaviors among women who inject drugs and use a syringe services program; Miami, Florida
by: Belén Hervera, et al.
Published: (2025-07-01)

Willingness to use long-acting injectable pre-exposure prophylaxis among key populations at a large HIV prevention clinic in Kampala, Uganda: a cross-sectional study
by: Jonathan Derrick Lukubuya, et al.
Published: (2025-08-01)

Tribally-affiliated syringe services programs in the United States: a brief report
by: Sean T. Allen, et al.
Published: (2025-08-01)

Applying population‐specific incidence prevalence ratio benchmarks to monitor the Australian HIV epidemic: an epidemiological analysis
by: Jonathan M. King, et al.
Published: (2024-12-01)

Telehealth to increase healthcare access; perspectives of people who use drugs
by: Zoi Papalamprakopoulou, et al.
Published: (2024-10-01)

Results of the Campaign Dedicated to World Hepatitis Day
by: V. V. Klushkina, et al.
Published: (2025-07-01)

Barriers and facilitators of COVID-19 vaccination among drug users: a qualitative analysis for future crisis management
by: Salah Eddin Karimi, et al.
Published: (2025-07-01)

Social Network Strategy improves access to HIV testing and harm reduction programs for PWID and their partners in Kazakhstan
by: Olga Denisiuk, et al.
Published: (2023-03-01)

A large-scale screening of hepatitis C among men who have sex with men in the community using saliva point-of-care testing
by: Sonia Albertos, et al.
Published: (2024-12-01)

Security and efficacy of intravenous injection of lidocaine in major hepatic resection
by: R. A. Zatsarynnyi, et al.
Published: (2022-12-01)

People who use drugs and the right to health
by: Alison Ritter, et al.
Published: (2024-12-01)

Ensuring that people who use drugs are safely and equitably included at meetings and conferences
by: Hannah L Brooks, et al.
Published: (2025-03-01)

Dual HIV risk and vulnerabilities among people who inject drugs in Iran: Findings from a nationwide study in 2020
by: Soheil Mehmandoost, et al.
Published: (2024-10-01)